ARCHIVES

Schmidt’s Term On Cancer Panel Expires, No Word On Reappointment

This article is from The Cancer Letter archive.

Vol. 01 No. 09 | February 28, 1975

Download PDF Visit The Full Archive

Related Articles

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

Intramural Review System Described

September 10, 1982

Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations

August 31, 2001

Protein Patterns May Identify Ovarian Cancer Earlier

March 29, 2002

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989

NCI-Approved Clinical Trials

September 29, 2006